Neuropsychiatric disorders are one of the main challenges of human medicine with epilepsy as one of the most common and serious disorders of the brain. Temporal lobe epilepsy represents the most common type of epilepsies and is often accompanied by marked neuronal degeneration. One main factor that causes neural loss is the excitotoxicity of glutamate, which is copiously released during seizures and hypoxia accompanying seizures. There is evidence that endogenous opioids, namely dynorphin (Dyn), act as modulators of neuronal excitability. It was also shown that the deletion of proDyn in mice and low expression in humans is associated with increased epilepsy vulnerability. Dyn targets opioid receptors and in particular the κ opioid receptor (KOP). The KOP receptors in the hippocampal formation are located in very strategically points for the control of the glutamate release and most important they are not altered under epileptic conditions. Interestingly, proDyn expression is reduced after an initial increase in most epilepsy models and activation of KOP receptors may be neuroprotective. Still, the functional background of these neuroprotective effects is not fully understood. The aim of this study was to investigate the influence of KOP agonists and antagonists on EEG patterns of epileptic mice.